Advertisement

Topics

LETI Pharma GmbH Company Profile

04:46 EST 17th December 2018 | BioPortfolio

Laboratorios LETIVor rd. 80 Jahren gründete Prof. Pedro Domingo Sanjuán in Spanien das Experimentallabor für therapeutische Immunologie. LETI steht für: 'Laboratorio Experimental de Terapéutica Immunógena'. Das junge Unternehmen machte sich einen Namen als Pionier bei der Entwicklung von Antibiotika und Impfstoffen. Bereits in den frühen 40er Jahren begann es mit der Entwicklung von Präparaten zur Diagnose und Behandlung von Allergien. Wichtige Schritte auf dem Weg zu Innovationen waren: Die Gründung der Firma C.B.F. (Corporación Biológica Farmacéutica) für Forschung und Entwicklung (1985) und die Einbindung von C.B.F. in nationale Forschungs- und Entwicklungsprogramme sowie in das Eureka-Programm der Europäischen Gemeinschaft (Programmschwerpunkt: ‚Allergy Innovations').
Die Firma C.B.F. wurde später in das Unternehmen Laboratorios LETI S.A. integriert und umbenannt in C.B.F. LETI S.A.. Der Unternehmensverbund LETI mit allen Einzelgesellschaften erwirtschaftete zuletzt einen Jahresumsatz von ca. DM 43 Millionen.

Location

Mannesmannstr. 4
Witten
D-58455
Germany

Contact

Phone: 02302 / 20 28 60
Fax: 02302 / 20 28 620
Email: info@leti.de


News Articles [655 Associated News Articles listed on BioPortfolio]

Heidelberg Pharma: GMP-Produktion von Krebswirkstoff etabliert

Frankfurt am Main (www.aktiencheck.de) - Heidelberg Pharma-Aktienanalyse von Analyst Thomas J. Schießle von der EQUI.TS GmbH: Thomas J. Schießle, Analyst der EQUI.TS GmbH, rät in einer aktuellen Ak...

Laboratorios LETI SL Strategic SWOT Analysis Review [Report Updated: 25072018] Prices from USD $125

Laboratorios LETI SL Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 26062018] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

DGAP-Adhoc: CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich (deutsch)

CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich DGAP-Ad-hoc: CO.DON AG / Schlagwort(e): Markteinführung CO.DON AG: CO.DON AG zeichnet....

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Pediapharm acquires rheumatology-focused Medac

Pediapharm Inc. acquired privately-held specialty pharmaceuticals company Medac Pharma Inc. (wholly owned subsidiary of German pharma medac GMBH) for total consideration of $50mm.

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

The Common Pharmaceutical Market of the Eurasian Economic Union: A Regulatory Review.

According to the Treaty on the Eurasian Economic Union, a common pharmaceutical market was supposed to become operational on January 1, 2016. Nevertheless, the responsible parties did not meet the dea...

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects

The purpose of this trial is to compare the pharmacokinetic characteristics of two isosorbide -5 -mononitrate extended -release tablets 40 mg of Qilu Pharmaceutical Co., Ltd and ISMO Retar...

Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF

"This is a randomised, double-blind, placebo-controlled multi-centre study to investigate safety and tolerability and to provide pharmacokinetic and pharmacodynamics information of orally ...

Companies [1283 Associated Companies listed on BioPortfolio]

LETI Pharma GmbH

Laboratorios LETIVor rd. 80 Jahren gründete Prof. Pedro Domingo Sanjuán in Spanien das Experimentallabor für therapeutische Immunologie. LETI steht für: 'Laboratorio Experimental de Terapéutica I...

Leti

CEA is a French research and technology public organisation, with activities in three main areas: energy, technologies for information and healthcare, and defence and security. Wi...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

CEA-Leti

CEA is a French research and technology public organisation, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security...

INJEX Pharma AG

INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the m...

More Information about "LETI Pharma GmbH" on BioPortfolio

We have published hundreds of LETI Pharma GmbH news stories on BioPortfolio along with dozens of LETI Pharma GmbH Clinical Trials and PubMed Articles about LETI Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LETI Pharma GmbH Companies in our database. You can also find out about relevant LETI Pharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...


Corporate Database Quicklinks



Searches Linking to this Company Record